These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 10785231

  • 1. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
    Rutanen E, Hurskainen R, Finne P, Nokelainen K.
    Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
    [Abstract] [Full Text] [Related]

  • 2. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
    Koh SC, Singh K.
    J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
    [Abstract] [Full Text] [Related]

  • 3. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel.
    Hurskainen R, Salmi A, Paavonen J, Teperi J, Rutanen E.
    Mol Hum Reprod; 2000 Nov; 6(11):1013-8. PubMed ID: 11044464
    [Abstract] [Full Text] [Related]

  • 4. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr 10; 102(1):74-9. PubMed ID: 12039094
    [Abstract] [Full Text] [Related]

  • 5. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.
    Istre O, Trolle B.
    Fertil Steril; 2001 Aug 10; 76(2):304-9. PubMed ID: 11476777
    [Abstract] [Full Text] [Related]

  • 6. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC, Virtanen-Kari S.
    BJOG; 2005 Aug 10; 112(8):1121-5. PubMed ID: 16045528
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U, Ebru A, Murat E, Levent Y.
    Int J Gynaecol Obstet; 2013 Nov 10; 123(2):146-9. PubMed ID: 24028852
    [Abstract] [Full Text] [Related]

  • 8. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF.
    Hum Reprod; 1998 May 10; 13(5):1210-7. PubMed ID: 9647549
    [Abstract] [Full Text] [Related]

  • 9. The levonorgestrel intrauterine system in the management of menorrhagia.
    Barrington JW, Bowen-Simpkins P.
    Br J Obstet Gynaecol; 1997 May 10; 104(5):614-6. PubMed ID: 9166207
    [Abstract] [Full Text] [Related]

  • 10. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
    Cameron IT.
    Eur J Contracept Reprod Health Care; 2001 Jan 10; 6 Suppl 1():27-32. PubMed ID: 11336431
    [Abstract] [Full Text] [Related]

  • 11. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N, Soysal S, Sayan S, Yildizhan B, Karaman E, Cetin O, Tolunay HE, Yildizhan R.
    Gynecol Obstet Invest; 2018 Jan 10; 83(6):569-575. PubMed ID: 29223999
    [Abstract] [Full Text] [Related]

  • 12. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2016 Jan 10; 16(18):1-119. PubMed ID: 27990196
    [Abstract] [Full Text] [Related]

  • 13. The levonorgestrel intrauterine system: therapeutic aspects.
    Luukkainen T.
    Steroids; 2000 Jan 10; 65(10-11):699-702. PubMed ID: 11108879
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
    Kriplani A, Singh BM, Lal S, Agarwal N.
    Int J Gynaecol Obstet; 2007 Jun 10; 97(3):190-4. PubMed ID: 17382331
    [Abstract] [Full Text] [Related]

  • 15. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
    Burton KA, Henderson TA, Hillier SG, Mason JI, Habib F, Brenner RM, Critchley HO.
    Hum Reprod; 2003 Dec 10; 18(12):2610-7. PubMed ID: 14645180
    [Abstract] [Full Text] [Related]

  • 16. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
    Inki P, Hurskainen R, Palo P, Ekholm E, Grenman S, Kivelä A, Kujansuu E, Teperi J, Yliskoski M, Paavonen J.
    Ultrasound Obstet Gynecol; 2002 Oct 10; 20(4):381-5. PubMed ID: 12383322
    [Abstract] [Full Text] [Related]

  • 17. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Contracept Reprod Health Care; 2001 Jun 10; 6(2):93-101. PubMed ID: 11518454
    [Abstract] [Full Text] [Related]

  • 18. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
    Ammälä M, Nyman T, Strengell L, Rutanen EM.
    Fertil Steril; 1995 Apr 10; 63(4):773-8. PubMed ID: 7890061
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system.
    Baron YM, Craus J, Agius RC, Brincat M.
    Gynecol Endocrinol; 2012 Sep 10; 28(9):694-8. PubMed ID: 22304721
    [Abstract] [Full Text] [Related]

  • 20. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
    Pakarinen PI, Lähteenmäki P, Lehtonen E, Reima I.
    Hum Reprod; 1998 Jul 10; 13(7):1846-53. PubMed ID: 9740437
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.